Expanding prescription naloxone Alex Walley & Maya Doe-Simkins on behalf of prescribetoprevent.org prescribetoprevent.org: Jenny Arnold, PharmD, BCPS Leo.

Slides:



Advertisements
Similar presentations
Daliah Heller, PhD, MPH Assistant Commissioner
Advertisements

Cindy Powers Magrini, PharmD, BCPS
The Washington State Pharmacist Perspective
Prevention Conference October 30 th, 2014 Help Save Lives in the Commonwealth Join The Massachusetts 911 Good Samaritan Campaign.
Recognizing and Preventing Overdose and Administering Naloxone Substance Use Disorder Treatment Professional Curricula Core.
Deaths Avoided With Naloxone What is Naloxone? Naloxone commonly known as Narcan is a medication that can reverse and overdose caused by an opioid drug.
Preventing Prescription Drug Abuse: Laws and Legislation Hollie Hendrikson, MSc Policy Specialist, Health Program.
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS.
Opioid Rescue Kits for Porter County Sheriff’s Department.
Law as Barrier to and Facilitator of Opioid Overdose Prevention Corey Davis, JD, MSPH Cross-System Collaboration to Respond to the Prescription Drug Epidemic.
Opioid Safety Phillip Coffin, MD, MIA Director of Substance Use Research San Francisco Dept. of Public Health Assistant Clinical Professor University of.
Strategies for Incorporating OD Prevention Into Your Work Eliza Wheeler Drug Overdose Prevention & Education (DOPE) Project Harm Reduction Coalition
Implementation in Ohio’s Regional Psychiatric Hospitals.
SILVER CROSS EMSS EMD CE September Heroin use is increasing, and so are heroin-related overdose deaths.
Naloxone (Narcan) A true opioid overdose antidote.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Prescription Drug Monitoring Programs: Analysis of State Level Usage Requirements Matthew Penn, JD, Carla Chen, JD Director, Public Health Law Program.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Rx for Success Next Steps to Prevent Prescription Drug Abuse Rebecca Hebner, MPH Substance Abuse Prevention Systems Coordinator.
To call 911 or not to call 911? Overdose help-seeking Alexander Y. Walley and Maya Doe-Simkins Co-authors: Ziming Xuan, Emily Quinn, Amy Sorensen- Alawad,
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
MBEMSC /PIER Committee
Single Convention on Narcotic Drugs Establishes a regulatory system for narcotic drugs government authorization is required for participation in the trade.
Texas State Board of Medical Examiners Bruce A. Levy, M.D., J.D.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Naloxone: Cost, Logistics, and Supply Issues Community Pharmacy Perspective Krystalyn Weaver, PharmD National Alliance of State Pharmacy Associations.
Maryland’s “Good Samaritan” Law Annotated Code of Maryland, Criminal Procedure §1-210 Effective October 1, 2015 September
Gerald Cochran, MSW, PhD; 1 Bethany Brodie, MSW; 1 Alice Bell, MSW, LCSW; 2 Alex Bennett, PhD 3 1 University of Pittsburgh, Pittsburgh PA; 2 Prevention.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
NALOXONE Presented by The RASE Project. Scope Of The Problem Opiate overdose is a major public health problem in the United States. Overdoses have increased.
The Impact on Caregivers of Young Adult Opioid Use Sarah Bagley MD Addiction Medicine Fellow Clinical Addiction Research and Education Unit Boston University.
Naloxone: Prescribing and Dispensing
Ill Naloxone February 7 th, 2015 Tom Rafferty. Opioid Dependency & Overdose Emergency Interventions For Overdose Future Of Naloxone Questions Rescue Kits.
Naloxone for Entities & Laysavers Aaron Kochar, J.D.
Daniel Wermeling, Pharm.D. Professor, College of Pharmacy University of Kentucky.
Opiate overdose. Opiate overdose (ONS, 2012) The most common acute cause of drug-related death is opiate overdose. Over half – 596 (57 per cent) - of.
Bystander Naloxone Training Saves Lives. Death rates are spiraling out of control--for both prescription opioids and heroin! Graphic: Nytimes.com.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
Naloxone use Objectives  In this slide set, you will learn: What naloxone (Narcan) is How it works when administered to a person who has overdosed on.
A DAY IN THE LIFE OF BOOTS QUEEN STREET STATION Lynda Allan Store Manager.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
HOPE Agenda Heroin, Opioid Prevention & Education WISCONSIN STATE REPRESENTATIVE JOHN NYGREN – ASSEMBLY DISTRICT 89.
Pharmacist Role in Naloxone Prescribing
Medication Assisted Treatment
or you can use Text Voting by texting ”nmpha” to 22333
Nebraska Prescription Drug Overdose Prevention Program Efforts
An overdose Reduction PlaN
McLean Hospital Division of Alcohol and Drug Abuse
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Opioid Overdose Responder Training
ROOM project Addressing the Opioid Epidemic in the U.P.
Naloxone and You Ryan Feldman, PharmD, BCPS
Wicomico County Local Behavioral Health Authority
Opiate Roundtable March 29, 2018 Karen Burgess, MD
Prescription Drug Monitoring Program
QC Harm Reduction Opioid Overdose Reversal Training
Prescription Drug Monitoring Program
Naloxone in North Carolina
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
QC Harm Reduction Opioid Overdose Reversal Training
Strategic Initiatives to Address Opioid Overdose & Addiction
Drug Overdose Prevention Program Awareness Training
OVERDOSE AWARENESS & NALOXONE TRAIN THE TRAINER
PMP Advisory Committee
Presentation transcript:

Expanding prescription naloxone Alex Walley & Maya Doe-Simkins on behalf of prescribetoprevent.org prescribetoprevent.org: Jenny Arnold, PharmD, BCPS Leo Beletsky, JD, MPH Alice Bell, LCSW Sarah Bowman, MPH Jef Bratberg, PharmD, BCPS Scott Burris, JD Nabarun Dasgupta, MPH Maya Doe-Simkins, MPH Traci Green, MSc, PhD Sammy McGowan Alexander Y. Walley, MD, MSc

Getting naloxone in overdose bystanders’ hands: Community models Distribution Model Nonmedical hand out nlx Nlx not at pharmacy Minimal record keeping No billing for nlx/services Legal gray area Modified Prescription Model Nlx not dispensed from pharmacy Records establish provider- pt relationship Provider or on-site delegate gives nlx No billing for nlx/svcs Less legal gray area Standing order: Off site dr authorized nonmedical person to train/give nlx Varies: person who gets nlx can be potential overdose bystander or must be potential overdose victim?

Legal Barriers to Prescription Model “ Prescribing naloxone in the USA is fully consistent with state and federal laws regulating drug prescribing. The risks of malpractice liability are consistent with those generally associated with providing healthcare, and can be further minimized by following simple guidelines presented.” 1.Prescribe to a person who is at risk for overdose (except IL, MA, WA, CT) 2.Ensure that the patient is properly instructed in the administration and risks of naloxone Burris S at al. “Legal aspects of providing naloxone to heroin users in the United States. Int J of Drug Policy 2001: 12;

Challenges for community programs Naloxone cost increasing, funding minimal Missing people who don’t identify as drug users, but have high risk Missing people who may periodically misuse opioids=no tolerance Opportunities for prescription naloxone Co-prescribe naloxone with opioids for pain Co-prescribe with methadone/ buprenorphine for addiction Insurance should fund this Increase patient, provider & pharmacist awareness Universalize overdose risk One person can start a program

Traditional prescription model elements Patient at risk for OD Prescriber gives rx for naloxone rescue kit + education Pt goes to pharmacy of choice to fill Pharmacist compounds rescue kit, offers education Pharmacist bills insurance (or charges pt directly) Pt gets naloxone rescue kit

Practical barriers to prescribing naloxone Patient at risk for OD Pt and/or prescriber must recognize OD risk

Practical barriers to prescribing naloxone Prescriber gives rx for naloxone rescue kit + education Prescriber comfort Patient inclusion criteria How to write prescription Institutional approval(?)

Practical barriers to prescribing naloxone Pt  pharmacy of choice to fill Groundwork necessary inhibitive- focus on main pharmacy(ies) patients use or internal (hospital) pharmacy

Practical barriers to prescribing naloxone Pharmacist “compounds” rescue kit, offers education Informed pharmacist Naloxone & delivery devices (MAD or syringes) in stock? Literature for patient(?)

Barriers to Traditional Prescription Pharmacist bills insurance (or pt) Medicaids often pay, private ins varies Doesn’t cover MAD (~$4) Some pharmacies absorb cost

Traditional Prescription Pt gets naloxone rescue kit!

Site visits > 5000 visits

Questions? Thank you!

What do visitors care about most? SectionVisits Prescribe Naloxone Now!1,552 Stocking/Paying for Naloxone & Billing1,293 FAQs515 Medico-Legal Resources460 Research & Other Resources430 About Us422 Welcome!238

Most popular clicks Click-able itemClicks Links to research papers500 Prescribing video100 Temple University’s state by state naloxone legal review 60

Most popular search terms Terms Variations of P2P Cost of naloxone/atomizer Sources to purchase naloxone &/ atomizer

Largest referral sources SourceVisits Search Engines 413 harmreduction.org 142 projectlazarus.org 122 stopoverdose.org 109 Facebook 81 pain-topics.org 46 Twitter 42

Overdose Education in Medical Settings Where is the patient at as far as overdose? – Ask your patients whether they have overdosed, witnessed an overdose or received training to prevent, recognize, or respond to an overdose Overdose history: 1.Have you ever overdosed? 1.What were you taking? 2.How did you survive? 2.What strategies do you use to protect yourself from overdose? 3.How many overdoses have you witnessed an overdose? 1.Were any fatal? 2.What did you do? 4.What is your plan if you witness an overdose in the future? 1.Have you received a narcan rescue kit? 2.Do you feel comfortable using it?

Overdose Education in Medical Settings What patients need to know: 1.Prevention - the risks: – Mixing substances – Abstinence- low tolerance – Using alone – Unknown source – Chronic medical disease – Long acting opioids last longer 2.Recognition – Unresponsive to sternal rub with slowed breathing – Blue lips, pinpoint pupils 3.Response - What to do Call for help Rescue breathe Deliver naloxone Continue rescue breathing for 3-5 minutes Stay until help arrives

Passed Massachusetts in August 2012: An Act Relative to Sentencing and Improving Law Enforcement Tools Good Samaritan provision: Protects people who overdose or seek help for someone overdosing from being charged or prosecuted for drug possession – Protection does not extend to trafficking or distribution charges Patient protection: A person acting in good faith may receive a naloxone prescription, possess naloxone and administer naloxone to an individual appearing to experience an opiate-related overdose. Prescriber protection: Naloxone or other opioid antagonist may lawfully be prescribed and dispensed to a person at risk of experiencing an opiate-related overdose or a family member, friend or other person in a position to assist a person at risk of experiencing an opiate-related overdose. For purposes of this chapter and chapter 112, any such prescription shall be regarded as being issued for a legitimate medical purpose in the usual course of professional practice.

Patient Selection After emergency medical care involving opioid intoxication or poisoning Suspected hx of substance abuse or nonmedical opioid use Patients taking methadone or buprenorphine Any patient receiving an opioid prescription for pain and: – higher-dose (>50 mg morphine equivalent/day) opioid – rotated from one opioid to another= poss incomplete cross tolerance – Smoking, COPD, emphysema, asthma, sleep apnea, respiratory infection, or other respiratory illness or potential obstruction. – Renal dysfunction, hepatic disease, cardiac illness, HIV/AIDS – Known or suspected concurrent heavy alcohol use – Concurrent benzodiazepine or other sedative prescription – Concurrent antidepressant prescription Patients who may have difficulty accessing emergency medical services (distance, remoteness) Voluntary request from patient or caregiver